Differentiating celiac disease from other diseases: Difference between revisions
Jump to navigation
Jump to search
Line 19: | Line 19: | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard dignosis | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard dignosis | ||
|- | |- | ||
!Watery | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Watery | ||
!Fatty | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatty | ||
!Weight loss | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Weight loss | ||
!FTT | ! align="center" style="background:#4479BA; color: #FFFFFF;" |FTT | ||
!Abdominal pain | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Abdominal pain | ||
|- | |- | ||
![[Celiac disease (patient information)|Celiac disease]] | ! align="center" style="background:#DCDCDC;" |[[Celiac disease (patient information)|Celiac disease]] | ||
| +/- | | +/- | ||
| +/- | | +/- | ||
Line 78: | Line 78: | ||
* [[Lactose]] breath hydrogen test | * [[Lactose]] breath hydrogen test | ||
|- | |- | ||
![[Cystic fibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ||
| - | | - | ||
| + | | + | ||
Line 103: | Line 103: | ||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
|- | |- | ||
![[Laxative abuse|Laxative overuse]] | ! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]] | ||
| + | | + | ||
| - | | - | ||
Line 126: | Line 126: | ||
** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]] | ** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]] | ||
|- | |- | ||
![[Crohns disease|Crohns disease]] | ! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]] | ||
| + | | + | ||
| - | | - | ||
Line 181: | Line 181: | ||
* [[TSH]] | * [[TSH]] | ||
|- | |- | ||
![[VIPoma]] | ! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ||
| + | | + | ||
| - | | - | ||
Line 210: | Line 210: | ||
* Followed by imaging | * Followed by imaging | ||
|- | |- | ||
![[Irritable bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ||
| + | | + | ||
| - | | - | ||
Line 232: | Line 232: | ||
** [[Pharmacological|Pharmacologic]] studies based criteria | ** [[Pharmacological|Pharmacologic]] studies based criteria | ||
|- | |- | ||
![[lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[lactose intolerance]] | ||
| - | | - | ||
| + | | + | ||
Line 256: | Line 256: | ||
|lactase activity assay | |lactase activity assay | ||
|- | |- | ||
![[Whipple's disease|Whipple disease]] | ! align="center" style="background:#DCDCDC;" |[[Whipple's disease|Whipple disease]] | ||
| +/- | | +/- | ||
| + | | + | ||
Line 275: | Line 275: | ||
|Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]]) | |Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]]) | ||
|- | |- | ||
!Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ||
| + | | + | ||
| - | | - | ||
Line 295: | Line 295: | ||
|[[oral]] food challenge (OFC) | |[[oral]] food challenge (OFC) | ||
|- | |- | ||
![[Eosinophilic gastroenteritis]] | ! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ||
| + | | + | ||
| - | | - | ||
Line 315: | Line 315: | ||
|[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | |[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
|- | |- | ||
![[Microscopic colitis]] | ! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ||
| + | | + | ||
| - | | - | ||
Line 344: | Line 344: | ||
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ||
|- | |- | ||
![[Congenital chloride diarrhea]] | ! align="center" style="background:#DCDCDC;" |[[Congenital chloride diarrhea]] | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 364: | Line 364: | ||
* Excessive [[Fecal|feca]]<nowiki/>l secretion of [[chloride]] | * Excessive [[Fecal|feca]]<nowiki/>l secretion of [[chloride]] | ||
|- | |- | ||
!Congenital sodium [[diarrhea]] | ! align="center" style="background:#DCDCDC;" |Congenital sodium [[diarrhea]] | ||
| + | | + | ||
| - | | - | ||
Line 384: | Line 384: | ||
|Clinical | |Clinical | ||
|- | |- | ||
![[Glucose|Glucose-]][[galactose]] [[malabsorption]] | ! align="center" style="background:#DCDCDC;" |[[Glucose|Glucose-]][[galactose]] [[malabsorption]] | ||
| + | | + | ||
| - | | - | ||
Line 404: | Line 404: | ||
* Positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]] | * Positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]] | ||
|- | |- | ||
![[Abetalipoproteinemia]] | ! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ||
| - | | - | ||
| + | | + | ||
Line 429: | Line 429: | ||
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level | * Clinical findings and low [[triglyceride]] and [[cholesterol]] level | ||
|- | |- | ||
!Primary bile acid malabsorption | ! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption | ||
| + | | + | ||
| +/- | | +/- | ||
Line 448: | Line 448: | ||
* [[Gamma emitter selenium-75-homocholic acid taurine]] (SeHCAT) | * [[Gamma emitter selenium-75-homocholic acid taurine]] (SeHCAT) | ||
|- | |- | ||
![[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]]<nowiki/>) | ! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]]<nowiki/>) | ||
| + | | + | ||
| - | | - |
Revision as of 11:33, 13 September 2017
Celiac disease Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Differentiating celiac disease from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating celiac disease from other diseases |
Differentiating celiac disease from other diseases in the news |
Risk calculators and risk factors for Differentiating celiac disease from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Differentiating Celiac Disease from Other Diseases
Celiac disease must be differentiated from other diseases presenting as chronic diarrhea. The table below summarizes the findings that differentiate causes of chronic diarrhea[1][2][3][4][5][6][7]
Cause | Diarrhea | Peak age of onset | History | Physical exam | Lab findings | Additional finding | Cause/Pathogenesis | Gold standard dignosis | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Watery | Fatty | Weight loss | FTT | Abdominal pain | |||||||
Celiac disease | +/- | +/- | Childhood
Adult |
+ | + | + |
|
|
|
| |
Lactose intolerance | + | - | Adult | - | - | + |
|
|
| ||
Cystic fibrosis | - | + | Infancy and childhood | + | + | + |
|
|
|
| |
Laxative overuse | + | - | After childhood | +/- | - | +/- |
|
|
- |
|
|
Crohns disease | + | - | Young adults
(20th) |
+ | + |
|
|
|
|
| |
Hyperthyroidism | + | - | Any age | + | - | +/- |
|
|
|||
VIPoma | + | - | Between 30 and 50 | + | +/- | +/- |
|
|
|
| |
Irritable bowel syndrome | + | - | Between 30 and 50 | - | - | + |
|
- |
|
| |
lactose intolerance | - | + | Any age | + | - | +/- |
|
|
|
lactase activity assay | |
Whipple disease | +/- | + | 50th | + | - | + |
|
Tropheryma whipplei | Upper endoscopy with biopsies of the small intestine for T. whipplei testing (histology with PAS staining, polymerase chain reaction [[[PCR]]] testing, and immunohistochemistry) | ||
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | + | - | Infancy | +/- | +/- | + | Stool examination:
|
|
Autoimmune/allergic response to food antigens | oral food challenge (OFC) | |
Eosinophilic gastroenteritis | + | - | 30th | +/- | +/- | + |
|
Autoimmune/allergic response to food antigens | eosinophilic infiltration of the gastrointestinal tract on biopsy | ||
Microscopic colitis | + | - | 60th | + | - | + |
|
|
|
| |
Congenital chloride diarrhea | + | - | Neonate | + | + | - | - |
|
Mutations in the SLC26A3 gene
|
||
Congenital sodium diarrhea | + | - | Neonate | + | + | - | - | Stool examination: |
|
|
Clinical |
Glucose-galactose malabsorption | + | - | Infancy | + | +/- | + | Abdominal tenderness | Stool examination:
|
|
|
|
Abetalipoproteinemia | - | + | Infancy | + | + | + |
|
|
|
|
|
Primary bile acid malabsorption | + | +/- | Childhood Adolescents | + | + | +/- | - |
|
|
|
|
Gastrinoma (Zollinger-Ellison syndrome) | + | - | Between the ages of 20 and 50 | + | +/- | + |
|
|
|
References
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
- ↑ Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
- ↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
- ↑ BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.